SNS M Ruhul Qudus Naim

S M Ruhul Qudus Naim

*This is an algorithmically generated author record based on publicly available information.

S M Ruhul Qudus Naim has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lurasidone in the management of Ketamine overdose

    by S M Ruhul Qudus Naim, Kashfia Nawrin, Mohammad Nurul Islam

    Background: Ketamine is an anesthetic compound that has recreational use and can cause heart-related toxicity, different psychiatric disorder, and even death. Nevertheless, the management of ketamine overdose is not yet perfect. Hence, the discovery or identification of compounds that can manage ketamine overdose is essential. Ketamine can induce schizophrenia and lurasidone can treat schizophrenia, on its basis, the present study was aimed to determine if lurasidone can alter ketamine-induced death and/or reduce recovery time from ketamine-induced anesthesia. Methods: Mice were initially injected with 50 mg/kg, 100mg/kg, 150mg/kg, and 200mg/kg i.p. ketamine for toxicity test, and any death was recorded. Based on the toxicity study, the lethal dose was determined (150mg/kg b.w.) and further administered intra-peritoneally to fresh mice groups followed by treatment with 0.5mg/kg, 1mg/kg, 2mg/kg lurasidone. Afterward, survival rate and recovery time were recorded. Results: Control (only ketamine) treated mice group showed only 20% survival, whereas all three doses of lurasidone were able to keep all of the mice alive. However, no significant difference was found between the applied doses of lurasidone. In addition, all three doses of lurasidone minimized recovery time compared to control in a dose-dependent manner. The fastest recovery time recorded was 54 minutes by 2 mg/kg of lurasidone-pretreated mice. Conclusion: Although lurasidone was able to reduce ketamine-induced mortality rate and recovery time, the mechanism of lurasidone by which it exhibits recovery against ketamine is yet to be explored.

  • Ketamine attenuates memory and motor impairment associated with Alzheimer’s disease

    by S M Ruhul Qudus Naim, Nawrin Kashfia, Islam Mohammad Nurul

    Background: Alzheimer's disease is a prevalent neurological condition that leads to dementia. The illness advances slowly through the destruction of neurons. Though loss of memory characterizes the disease, interestingly, recent reports also suggest motor coordination can influence or be affected by the disease. Ketamine is a common anesthetic medicine but its effect on nervous system is debatable. Most of the studies over ketamine’s effect on cognitive function were conducted with administration of high dose, whereas its potential at low dose remained undiscovered. Thus, the present study was aimed to assess the effect of low dose of ketamine as sole administration and in a combination with antioxidant on cognition and motor coordination in a mouse model of Alzheimer's disease. Methods: Mice were given scopolamine for seven days to elicit Alzheimer-like symptoms such as loss of memory and motor coordination. Afterwards, they either received intraperitoneal dose of 5, 10, 20 mg/kg of ketamine only or along with an antioxidant (a complex of Betacarotene, vitamin-C, and vitamin-E) for cognitive and motor function test. The cognitive behavior was assessed using the Y maze test, modified hole cross test, and Morris water maze test, and motor coordination was evaluated using the rotatod and pole test. Results: The study revealed that ketamine at 20 mg/kg body weight interferes with cognition and impairs motor coordination in Alzheimer's mouse model. Ketamine 10 mg/kg in combination with the antioxidant resulted in significant cognitive improvement however, exhibited marginal improvement in motor coordination. Though previously reported by other studies, antioxidant as a positive control could not produce significant effect on motor coordination as observed in this study. Conclusion: More research at the cellular and molecular level is required to understand the mechanism behind conservation of cognitive function. Moreover, the synergistic potential of the combination (antioxidants and ketamine) in ameliorating cognitive effects is to be explored.